Explore our leading non-coding and messenger RNA sequencing technologies tailored for precision genomic research in Brazil's academic, clinical, and agricultural sectors.
Brazil's biotechnology ecosystem is undergoing a massive transformation, driven by an expanding network of federal universities, research institutes like FIOCRUZ and the Butantan Institute, and a thriving AgTech sector. Non-coding RNA (ncRNA) sequencing—encompassing microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)—has emerged as a vital tool for understanding complex biological systems.
Unlike traditional protein-coding transcriptomics, ncRNA profiling reveals the intricate regulatory networks governing gene expression. In Brazil, this technology is actively deployed to address pressing challenges in tropical medicine, oncology, and crop resilience. By partnering with global genomics pioneers like Biomarker Technologies (BMKGene), Brazilian researchers gain access to state-of-the-art sequencing platforms and cloud-based bioinformatic pipelines that bypass the logistical and financial bottlenecks traditionally associated with local sequencing runs.
• Biodiversity & Bioeconomy: Mapping the transcriptome of unique Amazonian flora and fauna to discover novel therapeutic compounds.
• Tropical Health Research: Investigating host-pathogen ncRNA interactions in Dengue, Zika, and Chagas disease.
• AgTech Innovation: Developing climate-resilient crops (soybeans, sugarcane) through non-coding RNA mapping.
As a global agricultural powerhouse, Brazil relies heavily on crop yield optimization. Environmental stressors such as drought in the Cerrado region and pests like the soybean rust fungus present constant threats. Non-coding RNA sequencing allows Brazilian agronomists to identify regulatory RNAs that control stress responses in crops. By understanding how specific lncRNAs or miRNAs modulate drought tolerance, breeders can develop robust cultivars, securing food supplies and boosting export values.
Brazil's population is characterized by a high degree of genetic admixture. This diversity makes localized genomic and transcriptomic profiling essential for clinical oncology and personalized medicine. Researchers in major clinical hubs like São Paulo and Rio de Janeiro utilize ncRNA profiling to identify biomarkers for early cancer detection and therapy response. miRNAs and circRNAs, which are highly stable in biofluids, serve as non-invasive biomarkers (liquid biopsies) tailored to the specific genetic backgrounds of Brazilian patient cohorts.
The integration of third-generation long-read sequencing (PacBio and Oxford Nanopore) is redefining transcriptomics in South America. Researchers are transitioning from short-read sequencing to full-length isoform sequencing. This technological leap allows the direct detection of complex splice variants and structural variations in non-coding transcripts without assembly biases, providing unprecedented resolution of the dark matter of the genome.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.
By combining industry-leading platforms with high-throughput automation, we offer Brazilian researchers unmatched sequencing depth, accuracy, and turnaround efficiency.
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
• Advanced biomolecular laboratory instruments.
• Standard labs for sample extraction, library construction, clean rooms, and sequencing labs.
• Standard procedures from sample extraction to sequencing executed under strict SOPs.
Our self-developed BMKCloud platform features CPUs with 41,104 memory, 3 PB total storage, and 4,260 computing cores, delivering a peak computing power exceeding 121,708.8 Gflop per second. This enables researchers in Brazil to run complex transcriptomic assemblies and alignments remotely with ease.
A visual overview of our advanced molecular biology laboratories, clean rooms, and automated processing lines that guarantee high-quality sequencing outputs.









Our rigorous quality control systems and technology partnerships are backed by international standards and patents, ensuring reliability for every genomic project.
A comprehensive suite of multi-omics and transcriptomics solutions designed for advanced biological sequencing and molecular research.